首页 | 本学科首页   官方微博 | 高级检索  
     


Combining cancer immunotherapy and targeted therapy
Affiliation:1. Department of Medicine, Division of Hematology/Oncology, University of California Los Angeles (UCLA), and the Jonsson Comprehensive Cancer Center at UCLA, Los Angeles, CA, United States;2. Department of Surgery, University of California Los Angeles (UCLA), and the Jonsson Comprehensive Cancer Center at UCLA, Los Angeles, CA, United States;3. Department of Medical and Molecular Pharmacology, University of California Los Angeles (UCLA), and the Jonsson Comprehensive Cancer Center at UCLA, Los Angeles, CA, United States;4. Department of Medicine and Ludwig Center for Cancer Immunotherapy, Immunology Program, Memorial Sloan-Kettering Cancer Center, Weill-Cornell Medical College, New York, NY, United States;5. Ludwig Institute for Cancer Research, New York, NY, United States;1. Duke Brain Tumor Immunotherapy Program, Division of Neurosurgery, Department of Surgery, Duke University Medical Center, Durham, NC;2. Department of Biomedical Engineering, Duke University, Durham, NC;3. The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC;4. Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA;1. Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States;2. Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, United States;3. Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, United States;1. Department of Molecular Biology, Sejong University, 98 Gunja-dong, Kwangjin-gu, Seoul 143-747, Republic of Korea;2. Department of Chemistry, Sejong University, 98 Gunja-dong, Kwangjin-gu, Seoul 143-747, Republic of Korea;1. Department of Biostatistics, Harvard TH Chan School of Public Health, Boston, MA 02115, USA;2. Division of Biometrics V, Office of Biostatistics, Office of Translational Sciences, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA;3. Pfizer Inc, Groton, CT, USA;4. Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women''s Hospital, Boston, MA, USA;1. Melanoma and Immunotherapeutics Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA;2. Weill Cornell Medical College, New York, NY, USA;3. Parker Institute for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center, New York, NY, USA;4. Ludwig Collaborative and Swim Across America Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Abstract:
Keywords:
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号